| Alan M Demby, MD | |
|
1 Amalia Dr, Buckhannon, WV 26201-2239 | |
| (304) 460-7901 | |
| (304) 460-7909 |
| Full Name | Alan M Demby |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 1 Amalia Dr, Buckhannon, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225175920 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 21848 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alan M Demby, MD 1 Amalia Dr, Buckhannon, WV 26201-2239 Ph: (304) 460-7901 | Alan M Demby, MD 1 Amalia Dr, Buckhannon, WV 26201-2239 Ph: (304) 460-7901 |
News Archive
A University of Adelaide-led project has developed a new test that can distinguish between birds that have been vaccinated against the H5N1 strain of avian influenza virus or "bird flu" with those that have been naturally infected.
SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today that it has signed a License and Development Agreement with Roche and Genentech, Inc., a wholly-owned member of the Roche Group.
Results of a study by The Wistar Institute have described a correlation between a key melanoma signaling pathway and a novel class of drugs being tested in the clinic as adjuvant therapy for advanced melanoma, providing useful information for a more effective use of this type of treatment.
The impaired substrate metabolism of diabetes patients is often expressed in an increase in fatty deposits in the cells of the heart muscle. Until now, the exact cause of this was unknown. Now, researchers at the MedUni Vienna in the Division of Endocrinology and Metabolism of MedUni Vienna in cooperation with the MR Centre of Excellence Vienna have shown that high blood sugar in combination with high levels of insulin - not an influx of fats - results in such deposits within a few hours.
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T-cells to treat severe chronic inflammatory and autoimmune diseases, announces today that Stephane Boissel, CEO, TxCell and other senior management will either attend, present to, and meet investors at a number of leading forthcoming investor conferences.
› Verified 8 days ago
Douglas E Mckinney, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1 Amalia Dr, Buckhannon, WV 26201 Phone: 304-460-7901 |